Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TCT 2018

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT Daily Staff

September 28, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

Presentation TCT 2018

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Presenter: John G. Webb

September 23, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

Presentation TCT 2018

Neurology-Cardiology Partnership

Presenter: Robert J. Sommer, Christian Spies, Suzanne J. Baron, Reda Ibrahim, Carey D. Kimmelstiel, Srihari S. Naidu, Zoltan G. Turi, Dominik M. Wiktor

September 22, 2018

Presentation TCT 2018

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

Presenter: Charles J. Davidson, Jeffrey J. Popma, Matthew Summers

September 21, 2018

Video

» Interview

TCT 2017: Dr. C. Michael Gibson talks with Dr. David Cohen about PARTNER 2A and SAPIEN 3 Cost-effectiveness

May 11, 2018

Video

» Interview

Late Breaking Clinical Trial Interview: PARTNER II QUALITY OF LIFE: David J. Cohen, MD

May 11, 2018

Video

» Interview

Late Breaking Clinical Trial Interview: PARTNER I FIVE-YEAR ECHO: Pamela S. Douglas, MD

May 11, 2018

Video

» Interview

TCT 2016: Dr. C. Michael Gibson talks with Dr. David Cohen about PARTNER II QUALITY OF LIFE

May 11, 2018

Video

» Interview

TCT 2016: Dr. C. Michael Gibson talks with Dr. Pamela Douglas about PARTNER I FIVE-YEAR ECHO

May 11, 2018

Advertisement

Prosthetic Valve Endocarditis Rate Similarly Low for TAVR vs SAVR

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

High Mortality but Durable Results With Valve-in-Valve TAVR

PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Neurology-Cardiology Partnership

TCT-16: Incidence, Outcomes, And Microbiologic Profile Of Prosthetic Valve Endocarditis After TAVR And SAVR: Insights From PARTNER

TCT 2017: Dr. C. Michael Gibson talks with Dr. David Cohen about PARTNER 2A and SAPIEN 3 Cost-effectiveness

Late Breaking Clinical Trial Interview: PARTNER II QUALITY OF LIFE: David J. Cohen, MD

Late Breaking Clinical Trial Interview: PARTNER I FIVE-YEAR ECHO: Pamela S. Douglas, MD

TCT 2016: Dr. C. Michael Gibson talks with Dr. David Cohen about PARTNER II QUALITY OF LIFE

TCT 2016: Dr. C. Michael Gibson talks with Dr. Pamela Douglas about PARTNER I FIVE-YEAR ECHO

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content